Evelyn H. Orlando

Internal Medicine
622 W 168th St
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.

Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.

Journal: Leukemia & lymphoma
Published: August 14, 2025

Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.

Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.

Journal: Blood neoplasia
Published: January 15, 2025

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant.

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant.

Journal: Blood neoplasia
Published: December 09, 2024

EBV Reactivation and Lymphomagenesis: More Questions than Answers.

EBV Reactivation and Lymphomagenesis: More Questions than Answers.

Journal: Current hematologic malignancy reports
Published: July 11, 2023

Pilot Trial of Homebound Hematopoietic Cell Transplantation.

Pilot Trial of Homebound Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: May 17, 2022

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 18, 2015
Showing 1-6 of 6

Last Updated: 09/26/2026